Tuesday, December 13, 2011

Onyx (ONXX) (GHDX) (GLT) (IVR) (KOP) (LNC) (NKE) Price Targets Changed

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Genomic Health, Inc. (NASDAQ: GHDX), P.H. Glatfelter Company (NYSE: GLT), Invesco Mortgage Capital Inc. (NYSE: IVR), Koppers Holdings (NYSE: KOP), Lincoln National Co. (NYSE: LNC) and NIKE, Inc. (NYSE: NKE) had price targets on them adjusted by analysts.

Onyx Pharmaceuticals, Inc. ( ONXX) had its price target lowered by Goldman Sachs (NYSE:GS) to $45.00. They have a “Buy” rating on the company.

Genomic Health, Inc. (NASDAQ: GHDX) had its price target raised by analysts at Ladenburg Thalmann from $26.00 to $32.00. The analysts now have a “buy” rating on the company.

P.H. Glatfelter Company (NYSE: GLT) had its price target raised by Deutsche Bank (NYSE:DB) to $19.00. They have a “Buy” rating on the company.

Invesco Mortgage Capital Inc. (IVR) had its price target lowered by Wunderlich to $16.50. They have a “Hold” rating on the company.

Koppers Holdings (KOP) had its price target lowered by Jefferies (NYSE:JEF) to $43.00.

Lincoln National Co. (LNC) had its price target raised by RBC Capital from $22.00 to $24.00. They have a “Sector Perform” rating on the company.

NIKE, Inc. (NKE) had its price target raised by Stifel Nicolaus from $98.00 to $108.00. They have a “Buy” rating on the company.

No comments: